🇺🇸 FDA
Patent

US 11007201

Corticotropin releasing factor receptor antagonists

granted A61KA61K31/5377A61K31/573

Quick answer

US patent 11007201 (Corticotropin releasing factor receptor antagonists) held by SPRUCE BIOSCIENCES, INC. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPRUCE BIOSCIENCES, INC.
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/5377, A61K31/573, A61K9/14, A61K9/48